Viemed Healthcare, Inc. VMD
8.91
0.09
1.02%
as of 25 Sep
- Market cap
- $335.9M
- P/E
- 23.4×
Follow VMD
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 10.08% | 10.54% | 10.79% | 10.38% |
+8 more TTM periods Free account |
|
| 7.46% | 7.93% | 7.94% | 7.32% | ||
ROIC |
10.66% | 10.19% | 8.98% | 7.35% | |
Return on Tangible Assets |
17.42% | 17.50% | 17.32% | 15.77% | |
Average Days of Receivables |
39.00 | 39.71 | 34.86 | 42.01 | |
Free Cash Flow per Share |
0.90 | 0.95 | 0.72 | 0.60 | |
Free Cash Flow |
34.43 | 36.34 | 28.08 | 23.29 | |
Capital Expenditures |
(26.35) | (20.79) | (23.83) | (25.17) | |
Piotroski F-Score |
4.00 | 5.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
37.12% | 34.68% | 30.65% | 28.89% | |
Accounts Receivable Turnover |
10.26 | 9.89 | 10.66 | 9.04 | |
Accounts Payable Turnover |
13.34 | 14.72 | 18.15 | 14.62 | |
Inventory Turnover |
26.75 | 25.08 | 24.52 | 22.40 | |
Average Days of Payables |
31.26 | 25.75 | 23.31 | 29.49 | |
Days of Inventory on Hand |
14.99 | 15.56 | 16.04 | 17.92 | |
Tax Rate |
(0.29) | (0.30) | (0.29) | (0.30) | |
Research and Development Expense of Revenue |
0.81% | 0.98% | 1.12% | 1.26% | |
Selling, General and Administrative Expense of Revenue |
48.08% | 47.81% | 48.28% | 49.34% | |
Share Based Compensation of Revenue |
2.97% | 3.24% | 3.38% | 3.28% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
4.19 | 3.84 | 3.48 | 3.56 | |
Depreciation/Fixed assets |
0.40 | 0.39 | 0.37 | 0.34 | |
Capex/Depreciation |
(0.86) | (0.70) | (0.83) | (0.91) | |
Revenue per Share |
7.89 | 7.46 | 6.95 | 6.59 | |
Operating CF per Share |
1.59 | 1.49 | 1.33 | 1.25 | |
Capex per Share |
(0.69) | (0.54) | (0.61) | (0.65) | |
Capex to Sales |
0.09 | 0.07 | 0.09 | 0.10 | |
Net Profit Margin |
4.81% | 5.20% | 5.53% | 5.34% |
Columns are period end dates